{"id":"W4376143644","doi":"10.51731/cjht.2023.644","title":"Amivantamab (Rybrevant)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Epidermal growth factor receptor; Oncology; Drug; Chemotherapy; Disease; Lung cancer; Internal medicine; Intensive care medicine; Cancer; Pharmacology; Political science; Health care","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004196983,0.0003083289,0.0002994173,0.0006321236,0.0002027618,0.0006241505,0.0004276267,0.0007278604,0.01312487],"category_scores_gemma":[0.0005970123,0.00009061124,0.0005302007,0.0003502113,0.000229893,0.0004937991,0.0003241292,0.0009713183,0.004008368],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008700846,"about_ca_system_score_gemma":0.001032268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005174555,"about_ca_topic_score_gemma":0.01557093,"domain_scores_codex":[0.9997695,0.0000552303,0.00002298623,0.00004000239,0.00007987017,0.00003242595],"domain_scores_gemma":[0.9998534,0.00003456244,0.00004138804,0.000006821824,0.00003870108,0.00002507959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005983365,0.00009493241,0.0003918388,0.002593774,0.0001046105,0.0003266482,0.00004196044,0.0002678853,0.01180309,0.005176842,0.06084256,0.9177575],"study_design_scores_gemma":[0.0003846885,0.0009963382,0.002635766,0.001124036,0.0001267061,0.002211482,0.00002892337,0.0002045537,0.007245585,0.0007484383,0.9842679,0.00002550951],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02029034,0.8146613,0.002815122,0.008134396,0.002297644,0.000311678,0.00145373,0.0004184146,0.1496174],"genre_scores_gemma":[0.2179407,0.6226181,0.006973353,0.01202426,0.001271845,0.0003909958,0.004444671,0.00007529605,0.1342608],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01312487,"threshold_uncertainty_score":0.04390699,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03132594971319125,"score_gpt":0.3619167096172947,"score_spread":0.3305907599041035,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}